WHO ICTRP trial
The effects of rutin supplement on the brain of type 2 diabetes mellitus…
IRCT20151128025274N6 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20151128025274N6 |
|---|---|
| Public title | The effects of rutin supplement on the brain of type 2 diabetes mellitus patients |
| Scientific title | The effects of rutin flavonoid supplement on brain white matter neural tracts volume in type 2 diabetes mellitus patients by MRI |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Type 2 diabetes mellitus. Type 2 diabetes mellitus |
| Interventions | Intervention 1: Intervention group: Every day, one tablet of 1 g rutin (containing 500 mg of pure rutin and 500 mg other compounds include di-calcium phosphate, microcrystalline cellulose, plant cellulose, stearic acid, magnesium stearic… |
| Registration date | Jan 10, 2021 |
| Target size | 26 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: